NCT07177469: UBT251 Injection Phase II Study (Overweight or Obesity)
- State
- Completed
- Phase
- Phase 2
- People
- 205 taking part
- Started
- 14 Mar 2025
- Primary completion
- 22 Oct 2025
- Arms
- UBT251 Injection 4.0 mg(ID 1.0 mg)
- Results
- None posted
- 14 Mar 2025: Trial started
- 17 Sep 2025: Trial registered
- 19 Nov 2025: Trial completed